top of page

Company

Making disease biology visible earlier.

ImageNova Bioscience is building an AI-enabled molecular imaging platform to help biotech and pharmaceutical teams translate molecular hypotheses into quantitative in vivo evidence.

Our Mission

Our mission is to make disease biology visible earlier, so better therapeutic decisions can be made before costly clinical development.

Reveal biology in vivo
De-risk radiopharmaceutical and oncology programs
Turn imaging data into translational decisions

How We Work

Scientific clarity

Every study begins with a clear biological and development question.

Quantitative evidence

We prioritize measurable imaging endpoints, biodistribution patterns, tumor uptake, and translational interpretation.

Integrated execution

Imaging, radiochemistry, tumor models, and analysis are designed together rather than as disconnected services.

Partnership mindset

We work with biotech, pharma, academic, and investor teams to support better development decisions.

Silicon Valley Molecular Imaging Hub

ImageNova operates as a translational imaging hub designed to support early radiopharmaceutical and oncology development programs.

• microPET/CT imaging

• NIR-II optical imaging

• Probe synthesis and radiolabeling workflow

• Tumor model imaging support

• Quantitative image analysis

• Translational study design support

bottom of page